Discover 1,924 paid clinical trials in Hialeah, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,924
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
for
Parkinsons Disease (PD)
Location: Miami FL, Tampa FL, Jacksonville FL, Charleston SC,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 45 - 70+
Code: NCT06944522
Phase3, Recruiting
Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
for
Type 1 Diabetes, Diabetes Mellitus, Type 1
Location: Miami FL
Sponsor: Creative Medical Technology Holdings Inc
Sex: All
Age: 18 - 35
Code: NCT05626712
Phase1, Phase2, Recruiting
Breakthrough - T1DM and Chronic Kidney Disease
for
Diabete Type 1, Chronic Kidney Disease
Location: Miami FL, Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18 - 70
Code: NCT07592000
Phase1, Phase2, Recruiting
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
for
Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus
Location: Miami FL, Gainesville FL, Chapel Hill NC, Durham NC,
Sponsor: GentiBio, Inc
Sex: All
Age: 18 - 55
Code: NCT06919354
Phase1, Recruiting
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: Miami FL, Atlanta GA, Birmingham AL, Columbus OH,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT04973605
Phase1, Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Miami FL, Palmetto Bay FL, Boynton Beach FL,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06878261
Phase3, Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)